mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |